Sanofi says US DOJ closes FCPA inquiry

( March 7, 2018, 19:59 GMT | Official Statement) -- MLex Summary: Sanofi, a French pharmaceutical firm, said that the US Department of Justice last month closed an inquiry into allegations that the company may have violated the Foreign Corrupt Practices Act. The US Securities and Exchange Commission is still investigating the allegations. In March 2015, Sanofi disclosed that it had self-reported possible FCPA violations in the Middle East and Africa.Excerpt...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.

Know what others in the room don’t, with features including:

Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Prepare for tomorrow’s regulatory change, today

Related Sections